|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| Accretion of asset retirement obligation | |||||
| Share-based compensation | |||||
| Loss (gain) on sales of assets | |||||
| Non-cash interest expense | |||||
| Amortization of deferred financing costs | |||||
| Loss on extinguishment of debt | |||||
| (Gain) loss on derivative instruments | |||||
| Loss (gain) on foreign exchange | |||||
| Loss on impairment | |||||
| Income from equity affiliates | |||||
| Distributions from equity affiliates | |||||
| Deferred income taxes benefit | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables | |||||
| Inventories | |||||
| Excess of black lung benefit obligation over trust assets | |||||
| Accounts payable and accrued expenses | |||||
| Interest payable | |||||
| Deferred revenue | |||||
| Income tax payable | |||||
| Accrual for workers' compensation | |||||
| Other assets and liabilities | |||||
| Asset retirement obligations | |||||
| Accrual for postretirement medical benefits | |||||
| Pension and SERP obligations | |||||
| Return of derivative collateral | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from sales of restricted investments | |||||
| Purchases of restricted investments | |||||
| Cash payments in escrow for future acquisitions | |||||
| Cash payments related to acquisitions and other | |||||
| Cash acquired related to acquisition, net | |||||
| Proceeds from sales of assets | |||||
| Proceeds from the sale of restricted investments | |||||
| Payments related to loan and lease receivables | |||||
| Receipts from loan and lease receivables | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Change in book overdrafts | |||||
| Borrowings from long-term debt, net of debt discount | |||||
| Repayments of long-term debt | |||||
| Borrowings on revolving lines of credit | |||||
| Repayments on revolving lines of credit | |||||
| Debt issuance costs and other refinancing costs | |||||
| Preferred dividends paid | |||||
| Proceeds from issuance of common shares | |||||
| Exercise of stock options | |||||
| Redemption of preferred stock | |||||
| Distributions to noncontrolling interests | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash transactions: | |||||
| Accrued purchases of property and equipment | |||||
| Capital leases and other financing sources | |||||
Loading...